Literature DB >> 22692800

Treatment of nonconvulsive status epilepticus.

Trudy Pang1, Frank W Drislane.   

Abstract

OPINION STATEMENT: Status epilepticus is a neurologic emergency with significant potential morbidity and even mortality. It should be diagnosed and treated as quickly as possible, with concurrent rapid identification of the underlying cause. Nonconvulsive status epilepticus can be difficult to diagnose due to its protean manifestations, so a high index of suspicion is vital to prompt diagnosis and effective management. There are several different types and syndromes of nonconvulsive status epilepticus, and appropriate treatment varies according to those types. Some are relatively benign. Others, particularly the nonconvulsive status encountered in sick, hospitalized patients, can be life-threatening. The latter should be treated much more rapidly and aggressively than the former, sometimes even requiring coma-inducing anesthetic agents.

Entities:  

Year:  2012        PMID: 22692800     DOI: 10.1007/s11940-012-0179-4

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  71 in total

1.  The role of ketogenic diet in the treatment of refractory status epilepticus.

Authors:  Sook Hyun Nam; Bo Lyun Lee; Cha Gon Lee; Hee Joon Yu; Eun Yeon Joo; Jeehun Lee; Munhyang Lee
Journal:  Epilepsia       Date:  2011-10-17       Impact factor: 5.864

2.  Nonconvulsive status epilepticus of frontal origin.

Authors:  P Thomas; B Zifkin; O Migneco; C Lebrun; J Darcourt; F Andermann
Journal:  Neurology       Date:  1999-04-12       Impact factor: 9.910

3.  Increased cortical GABA concentrations in depressed patients receiving ECT.

Authors:  Gerard Sanacora; Graeme F Mason; Douglas L Rothman; Fahmeed Hyder; James J Ciarcia; Robert B Ostroff; Robert M Berman; John H Krystal
Journal:  Am J Psychiatry       Date:  2003-03       Impact factor: 18.112

4.  Complex partial status epilepticus accompanied by serious morbidity and mortality.

Authors:  A Krumholz; G Y Sung; R S Fisher; E Barry; G K Bergey; L M Grattan
Journal:  Neurology       Date:  1995-08       Impact factor: 9.910

5.  Continuous electroencephalography in the medical intensive care unit.

Authors:  Mauro Oddo; Emmanuel Carrera; Jan Claassen; Stephan A Mayer; Lawrence J Hirsch
Journal:  Crit Care Med       Date:  2009-06       Impact factor: 7.598

6.  The ketogenic diet in treatment of two adults with prolonged nonconvulsive status epilepticus.

Authors:  Courtney J Wusthoff; Sarah M Kranick; James F Morley; A G Christina Bergqvist
Journal:  Epilepsia       Date:  2009-10-20       Impact factor: 5.864

7.  Status epilepticus at an urban public hospital in the 1980s.

Authors:  D H Lowenstein; B K Alldredge
Journal:  Neurology       Date:  1993-03       Impact factor: 9.910

8.  Bilateral anterior thalamic nucleus lesions are not protective against seizures in chronic pilocarpine epileptic rats.

Authors:  Clement Hamani; Flavio I S Ewerton; Flávia Marcolin de Almeida; Saulo M Bonilha; Luciene Covolan; Clarissa Fantin Cavarsan; Gerson Ballester; Luiz E Mello; Andres M Lozano
Journal:  Stereotact Funct Neurosurg       Date:  2009-03-24       Impact factor: 1.875

9.  Successful treatment for refractory convulsive status epilepticus by non-parenteral lacosamide.

Authors:  Christian Tilz; Roland Resch; Thomas Hofer; Christian Eggers
Journal:  Epilepsia       Date:  2009-08-08       Impact factor: 5.864

10.  Treatment of Convulsive and Nonconvulsive Status Epilepticus.

Authors:  Trudy Pang; Lawrence J Hirsch
Journal:  Curr Treat Options Neurol       Date:  2005-07       Impact factor: 3.972

View more
  2 in total

1.  Intravenous anesthesia in treatment of nonconvulsive status epilepticus: Characteristics and outcomes.

Authors:  Utku Uysal; Mark Quigg; Brennen Bittel; Nancy Hammond; Theresa I Shireman
Journal:  Epilepsy Res       Date:  2015-07-26       Impact factor: 3.045

2.  [Non-convulsive status epilepticus: temporary fad or reality in need of treatment?].

Authors:  F Rosenow; S Knake; H M Hamer
Journal:  Nervenarzt       Date:  2012-12       Impact factor: 1.214

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.